Publication | Closed Access

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients

Multiple Sclerosis PatientsAutoimmune DiseaseDisease ProgressionNeurological DisorderMedicineImmunologyGene Expression StudyBiomarkersAutoimmunityNeurologyMultiple SclerosisMolecular DiagnosticsImmune-related Gene PolymorphismNeuroimmunologyCandidate Biomarkers